About

2020

Austin, Texas

Biotech, Artificial Intelligence (AI)

Pharmaceutical scientists spend thousands of hours on microscopy image analysis. Biodock’s AI platform automates that work to minutes.

Funding

$2.1 million

Undisclosed

Andreessen Horowitz, TQ Ventures, Soma Capital

As of March 2021, scientists at 100+ organizations use Biodock, including Vaxxas, Genentech, CSL Behring, PIC Therapeutics, Dewpoint Therapeutics, and Arvinas.

As of March 2021, Biodock reports its modules are 50% more accurate than other software solutions.

Michael Lee: Co-Founder & CEO of Biodock. Former Deep Learning Researcher at Stanford University School of Medicine.